Eric Raabe, MD, PhD
A single pivotal experience that occurred years ago influenced Dr. Eric Raabe’s decision to become a pediatric oncologist.Dr. Raabe was an undergraduate student volunteering at a children’s hospital. He had gotten to know an adolescent pediatric cancer patient during his volunteer stint, and vividly
Stacie Stapleton, MD
Dr. Stapleton is the director of pediatric neuro-oncology at Johns Hopkins All Children’s Hospital. Dr. Stapleton joined the hospital in 2007 and is double-board certified by the American Board of Pediatrics in general pediatrics and pediatric hematology/oncology. She has formal training in pediatri
Eric M. Jackson, MD
Dr. Eric Jackson specializes in the evaluation and treatment of patients with a broad range of neurosurgical disorders, including congenital malformations of the brain and spine, hydrocephalus (including endoscopic treatment), chiari malformation, craniosynostosis, spinal dysraphism/tethered cord, b
Headquartered in Baltimore, Maryland, Johns Hopkins Medicine unites physicians and scientists of the Johns Hopkins University School of Medicine with the organizations, health professionals and facilities of The Johns Hopkins Hospital and Health System. Johns Hopkins Medicine has six academic and community hospitals, four suburban health care and surgery centers, over 40 patient care locations, a home care group and an international division, and it offers an array of health care services.
Kenneth Seidl | Clinical Research Coordinatorhttps://www.hopkinsmedicine.org/
Chetan Bettegowda, MD, PhD
Identify key genetic pathways that are altered in brain tumors; Developing clinical trials to selectively target these pathways; Developing targeted therapies for patients with primary and metastatic tumors of the brain and spine; Ongoing clinical protocol to develop a simple blood test that can det
Linda M. Smith-Resar, MD
Basic research focus is hematologic malignancy and molecular mechanisms that lead to cancer.; Clinical research interests include sickle cell anemia.
Ranjan Perera, PhD
Dr. Perera is director of the Center for RNA Biology at Johns Hopkins All Children's Hospital, a senior scientist in the Cancer & Blood Disorders Institute and an associate professor of oncology in the Johns Hopkins University School of Medicine. He also has a secondary affiliation with the Johns Ho
Jeffrey Rubens, MD
Dr. Rubens' research focuses on developing new precision therapies that will rapidly translate into clinical trials aimed at reducing morbidity and improving survival in pediatric brain tumors.
Mari Groves, MD
Spinal Deformity; Skeletal Dysplasia; Intramedullary Spinal Cord Tumors
Michael A. Koldobskiy, MD, PhD, MS
Dr. Koldobskiy is an Instructor of Pediatric Oncology and Pediatric Neuro-Oncology at the Sidney Kimmel Comprehensive Cancer Center. He received his B.S. and M.S. from Yale University and M.D./Ph.D. in the Medical Scientist Training Program at Johns Hopkins, conducting his thesis research with Dr.
Fausto Jose Rodriguez, MD
Dr. Rodriguez’ research focuses on the identification of diagnostic, prognostic and therapeutic biomarkers in primary brain tumors. His current research activities aim to characterize molecular changes and signaling pathway alterations associated with the development of pediatric gliomas, as well as
Kenneth Seidl, BSN, RN
I am the research nurse primarily managing pediatric brain tumor research at Johns Hopkins. I have been working in the pediatric oncology department at Hopkins since 2015 and entered my research role in 2018. Since Hopkins’s collaboration with CBTN in mid-2020, I am responsible for recruiting, enr
Alan R. Cohen, MD
Dr. Cohen is the director of the Johns Hopkins Division of Pediatric Neurosurgery and the Carson-Spiro Professor of Pediatric Neurosurgery. He treats all pediatric patients, with a focus on brain tumors. Dr. Cohen sees patients at the Johns Hopkins Outpatient Center’s Neurosciences Clinic.Dr. Cohen
Charles Eberhart, MD, PhD
Dr. Charles Eberhart is a professor of pathology, oncology, and ophthalmology, at the Johns Hopkins University School of Medicine. His research primarily focuses on molecular genetics and treatment of medulloblastoma, glioblastoma, uveal melanoma and other tumors of the brain and eye. Dr. Eberhart s
Kenneth Cohen, MD, MBA
Dr. Cohen is Director of Pediatric Neuro-Oncology and Clinical Director of the Division of Pediatric Oncology at the Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins. He received his undergraduate degree at Brown University and earned his MD at the Upstate Medical University, in Syracuse,